Innovative Oncology Focus Barricade Therapeutics specializes in targeting cancer biology with novel first-in-class small molecules, creating opportunities for partnerships in early-stage drug development, research collaborations, and licensing of innovative cancer therapies.

Recent Funding Boost With a recent $14 million CPRIT grant dedicated to colorectal cancer, the company may be interested in expanding its research capabilities, potentially seeking suppliers, technology partners, or additional funding sources to accelerate product development.

Small but Growing As a small team with 2-10 employees and a revenue range up to 10 million dollars, Barricade presents opportunities for specialized biotech services, tailored instrumentation, and niche contract research organizations seeking to support emerging biotech firms.

Strategic Location Based in Dallas-Fort Worth, TX, the company is positioned in a growing biotech hub, making it accessible for regional collaborations, regional clinical trials, and partnerships with local biotech incubators or academic institutions.

Technological Sophistication Utilizing advanced tech stacks such as WordPress, cloud services, and complex molecular synthesis tools, Barricade may be open to technology-driven solutions, including data analytics, cloud storage, or scientific software to enhance its research processes.